Publications

Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.

Vishwanath, S., Carnell, G. W., Billmeier, M., Ohlendorf, L., Neckermann, P., Asbach, B., ... & Heeney, J. L. (2024). npj Vaccines, 9(1), 164.

Digitally immune optimised haemagglutinin with nanocage plug-and-display elicits broadly neutralising pan-H5 influenza subtype vaccine responses [Preprint].

Huang, C. Q., Hills, R. A., Carnell, G. W., Vishwanath, S., Aguinam, E. T., Chan, A. C., ... & Heeney, J. L. (2024). bioRxiv, 2024-11.

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature.

Cantoni, D., Wilkie, C., Bentley, E. M., Mayora-Neto, M., Wright, E., Scott, S., ... & Temperton, N. J. (2023). Frontiers in Immunology, 14, 1184362.

A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses.

Vishwanath, S., Carnell, G. W., Ferrari, M., Asbach, B., Billmeier, M., George, C., ... & Heeney, J. L. (2023). Nature Biomedical Engineering, 1-14.

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.

Carnell, G. W., Billmeier, M., Vishwanath, S., Suau Sans, M., Wein, H., George, C. L., ... & Heeney, J. L. (2023). Frontiers in Immunology, 14, 1118523.

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) neuraminidase pseudotypes as tools for pandemic preparedness and improved influenza vaccine design.

da Costa, K. A., Del Rosario, J. M. M., Ferrari, M., Vishwanath, S., Asbach, B., Kinsley, R., ... & Temperton, N. J. (2022). Vaccines, 10(9), 1520.

Human seasonal coronavirus neutralization and COVID‐19 severity.

Wells, D. A., Cantoni, D., Mayora‐Neto, M., Genova, C. D., Sampson, A., Ferrari, M., ... & Heeney, J. L. (2022). Journal of medical virology, 94(10), 4820-4829.

Gene delivery of a single, structurally engineered Coronavirus vaccine antigen elicits SARS-CoV-2 Omicron and pan-Sarbecovirus neutralisation [Preprint].

Heeney, J., Vishwanath, S., Carnell, G., Ferrari, M., Asbach, B., Billmeier, M., ... & Frost, S. (2022). Research Square. https://doi.org/10.21203/rs.3.rs-995273/v1

Exploiting pan influenza A and pan influenza B Pseudotype libraries for efficient vaccine antigen selection.

Del Rosario, J. M. M., Da Costa, K. A., Asbach, B., Ferrara, F., Ferrari, M., Wells, D. A., ... & Temperton, N. J. (2021). Vaccines, 9(7), 741.